In the light of the increasing incidents of Hospital Acquired Infections (HAIs), BD-India, a leading medical technology company in the country launched patient safety campaign in more than 150 hospitals in multiple cities across India. The campaign aims to enhance awareness amongst hospitals on minimising the risk of catheter related bloodstream infection (CRBSI) for patients.
The campaign has seen participation from heads of departments of Intensive Care, Anesthesiology, Microbiology; Medical Superintendents and Nursing in these hospitals.
CRBSIs are an important cause of hospital-acquired infection associated with morbidity, mortality, and cost. Through this month-long campaign, healthcare professionals were sensitized on processes and guidelines for reducing Hospital Acquired Infections (HAI) to ensure better healthcare outcomes and safety. Nosocomial infections or HAI can be defined as those infections occurring within 48 hours of hospital admission, 3 days of discharge or 30 days of an operation thus resulting in poor patient outcomes and increased healthcare costs.
Dr. Srishti Jain, “Asst.Prof, Department of Critical Care, Mahatma Gandhi Medical College & Hospital, said “HAIs represent a considerable burden on patients and hospital resources. Minimizing risks of CRBS infections becomes critical in every healthcare setting that can help in enhanced patient outcomes. Through this awareness campaign by BD, our staff will now be better informed and equipped to drive better patient outcomes.”
Added Pavan Mocherla, Managing Director, BD India & South Asia,“BD is continuously working to improve patient safety and protect patients from Hospital Acquired Infections (HAI). We can together with healthcare providers advance the delivery of healthcare if we address the need for appropriate technology and its training.”
According to WHO, over 1.4 million people across the globe suffer from a nosocomial infection. Also, this accounts for about 80,000 deaths a year. On an average, a patient with hospital acquired infection spent 2.5 times longer in hospital incurring additional costs and complicated treatment than an uninfected patient.
As per the study done by Dr. Victor D Rosenthal and published in American Journal of Infection control (2015), the use of Split Septum + Single-use prefilled flushing devices is cost-effective and associated with a significantly lower CLABSI rate compared with the use of Three-way stopcocks.